The global neurothrombectomy devices market size was estimated to be USD 0.74542 billion in 2023 and is expected to reach at USD 1.5577 billion by 2033 with a CAGR of 6.93% during the forecast period 2023-2033. Rising prevalence of acute ischemic stroke, growing adoption of unhealthy lifestyle, increasing awareness among the population regarding neurological conditions such as stroke, surge in introduction of technologically advanced products, rising focus on development of various technologies used in neurothrombectomy devices for the treatment of AIS & its associated symptoms, and increasing regulatory approvals for advanced devices are some of the key factors boosting the market growth.
Increasing regulatory approvals for advanced devices is predicted to boost the market growth during the forecast period. For instance, in January 2023, Infinity Neuro has received CE Mark approval for its first product, the Inspira aspiration catheters. This marks the company's initial step into the market. They have ambitious plans for the future, as they aim to introduce a comprehensive range of products designed to treat both ischemic and hemorrhagic stroke in 2023 and beyond.
By Product, Clot retriever was the highest revenue-grossing segment in the global neurothrombectomy devices market in 2022 owing to the increasing usage for removing blood clots from the cerebral arteries, growing prevalence of acute ischemic stroke, rising geriatric population, and surge in number of product launches by leading market players. Additionally, Aspiration/suction devices is predicted to grow at fastest CAGR during the forecast period owing to its rising demand among physicians, increasing prevalence of neurological disorders, growing usage of cutting-edge technology for the treatment of stroke, and surge in introduction of advanced products. For instance, in November 2020, Philips has introduced the QuickClear mechanical thrombectomy system, which includes an integrated aspiration pump that effectively eliminates blood clots from venous systems and peripheral arterial vessels in a single device.
By End-user, Hospital was the highest revenue-grossing segment in the global neurothrombectomy devices market in 2022 owing to the increasing hospital preference among population, surge in development of healthcare facilities, accessibility of cutting-edge technology, rising prevalence of acute ischemic diseases, increasing awareness regardign neurothrombectomy devices, growing demand for reperfusion therapy using neurothrombectomy devices for acute ischemic stroke. Additionally, Ambulatory Surgical Centers (ASCs) is predicted to grow at fastest CAGR during the forecast period owing to the reduced wait times provided to patients by ASCs, growing demand for minimally invasive surgical procedures, rising launch of technologically advanced products. For instance, in October 2021, Phenox GmbH has introduced the pRESET 6-50 mechanical thrombectomy device on a global scale, aiming to enhance their technology for addressing acute ischemic stroke cases. This product stands out in the Phenox product lineup, boasting the longest stent retriever available.
Europe region is anticipated for the highest revenue share during the forecast period owing to the surge in number of patients suffering from acute ischemic stroke, growing focus on development of innovative technologies, rising investments by government & private organizations, increasing regulatory approvals for neurothrombectomy devices, surge in launch of new products, surge in usage of advanced devices for the treatment of ischemic stroke. For instance, in April 2021, Perflow Medical has reported the initial and successful clinical application of the Stream17 dynamic neurothrombectomy net in treating patients with both hemorrhagic and ischemic strokes. Additionally, North America region is predicted to grow at fastest CAGR during the forecast period owing to the increasing population base, growing risk of acute ischemic stroke disorder, rising technological advancements, presence of major market players, increasing investments for the development of innovative medical devices by governments, growing demand for minimally invasive surgeries, rising awareness initiatives regarding advanced devices, growing investment in research & development activities, and surge in initiatives by market players. For instance, in April 2021, The NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) was developed by the Society of Neurointerventional Surgery (SNIS), NeuroPoint Alliance (NPA), and Society of Vascular and Interventional Neurology (SVIN).
Increasing regulatory approvals for advanced devices is predicted to boost the market growth during the forecast period. For instance, in January 2023, Infinity Neuro has received CE Mark approval for its first product, the Inspira aspiration catheters. This marks the company's initial step into the market. They have ambitious plans for the future, as they aim to introduce a comprehensive range of products designed to treat both ischemic and hemorrhagic stroke in 2023 and beyond.
By Product, Clot retriever was the highest revenue-grossing segment in the global neurothrombectomy devices market in 2022 owing to the increasing usage for removing blood clots from the cerebral arteries, growing prevalence of acute ischemic stroke, rising geriatric population, and surge in number of product launches by leading market players. Additionally, Aspiration/suction devices is predicted to grow at fastest CAGR during the forecast period owing to its rising demand among physicians, increasing prevalence of neurological disorders, growing usage of cutting-edge technology for the treatment of stroke, and surge in introduction of advanced products. For instance, in November 2020, Philips has introduced the QuickClear mechanical thrombectomy system, which includes an integrated aspiration pump that effectively eliminates blood clots from venous systems and peripheral arterial vessels in a single device.
By End-user, Hospital was the highest revenue-grossing segment in the global neurothrombectomy devices market in 2022 owing to the increasing hospital preference among population, surge in development of healthcare facilities, accessibility of cutting-edge technology, rising prevalence of acute ischemic diseases, increasing awareness regardign neurothrombectomy devices, growing demand for reperfusion therapy using neurothrombectomy devices for acute ischemic stroke. Additionally, Ambulatory Surgical Centers (ASCs) is predicted to grow at fastest CAGR during the forecast period owing to the reduced wait times provided to patients by ASCs, growing demand for minimally invasive surgical procedures, rising launch of technologically advanced products. For instance, in October 2021, Phenox GmbH has introduced the pRESET 6-50 mechanical thrombectomy device on a global scale, aiming to enhance their technology for addressing acute ischemic stroke cases. This product stands out in the Phenox product lineup, boasting the longest stent retriever available.
Europe region is anticipated for the highest revenue share during the forecast period owing to the surge in number of patients suffering from acute ischemic stroke, growing focus on development of innovative technologies, rising investments by government & private organizations, increasing regulatory approvals for neurothrombectomy devices, surge in launch of new products, surge in usage of advanced devices for the treatment of ischemic stroke. For instance, in April 2021, Perflow Medical has reported the initial and successful clinical application of the Stream17 dynamic neurothrombectomy net in treating patients with both hemorrhagic and ischemic strokes. Additionally, North America region is predicted to grow at fastest CAGR during the forecast period owing to the increasing population base, growing risk of acute ischemic stroke disorder, rising technological advancements, presence of major market players, increasing investments for the development of innovative medical devices by governments, growing demand for minimally invasive surgeries, rising awareness initiatives regarding advanced devices, growing investment in research & development activities, and surge in initiatives by market players. For instance, in April 2021, The NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) was developed by the Society of Neurointerventional Surgery (SNIS), NeuroPoint Alliance (NPA), and Society of Vascular and Interventional Neurology (SVIN).
Segmentation: Neurothrombectomy Devices Market Report 2022 - 2033
Neurothrombectomy Devices Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Mn)
- Aspiration/ Suction Devices
- Vascular Snares
- Clot Retrievers
Neurothrombectomy Devices Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Mn)
- Hospitals
- Emergency Clinics
- Ambulatory Surgical Centers (ASCs)
Neurothrombectomy Devices Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Mn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis
8. Neurothrombectomy Devices Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Neurothrombectomy Devices Market
11. Europe Global Neurothrombectomy Devices Market
12. Asia Pacific Global Neurothrombectomy Devices Market
13. Latin America Global Neurothrombectomy Devices Market
14. MEA Global Neurothrombectomy Devices Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Penumbra Inc.
- Medtronic
- Phenox GmbH
- Teleflex Incorporated
- Vesalio
- Infinity Neuro
- Philips
- Perflow Medical
- Boston Scientific Corporation
- Acandis GmbH
- Stryker Corporation
- MicroVention Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 0.75 Billion |
| Forecasted Market Value ( USD | $ 1.56 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
